Colonic epithelial cell proliferation in hereditary non-polyposis colorectal cancer

Gut

Volumn 43, Issue 1, 1998, Pages 85-92

  Green, S E ^a,c   Chapman, P ^a   Burn, J ^a   Burt, A D ^b   Bennett, M ^b   Appleton, D R ^a   Varma, J S ^a   Mathers, J C ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b ROYAL VICTORIA INFIRMARY   (United Kingdom)

^c University of Newcastle upon Tyne ^*  (United Kingdom)

Author keywords

Cell proliferation; Hereditary non polyposis colorectal cancer

Indexed keywords

BIOLOGICAL MARKER; MONOCLONAL ANTIBODY KI 67;

ADOLESCENT; ADULT; AGED; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; COLON MUCOSA; COLORECTAL CANCER; CONTROLLED STUDY; CRYPT CELL; EPITHELIUM CELL; FAMILIAL CANCER; HETEROZYGOTE; HUMAN; HUMAN CELL; LABELING INDEX; MITOSIS INDEX; PHENOTYPE; PRIORITY JOURNAL;

EID: 0031813288     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.43.1.85     Document Type: Article

References (66)

1. Lipkin M. Phase 1 and phase 2 proliferative lesions of colonic epithelial cells in diseases leading to colonic cancer. Cancer 1974;34:878-88.
2. Bleiberg H, Buyse M, Galand P. Cell kinetic indicators or premalignant stages of colorectal cancer. Cancer 1985;56: 124-9.
3. Deschner E, Winawer SJ, Long FC, et al. Early detection of colonic neoplasia in patients at high risk. Cancer 1977;40: 2625-31.
4. Deschner E, Maskens AP. Significance of the labelling index and labelling distribution as kinetic parameters in colorectal mucosa of patients and DMH treated animals. Cancer 1982;50:1136-41.
5. Lipkin M, Blattner WE, Fraumeni JE, et al. Tritiated thymidine labelling distribution as a marker for hereditary predisposition to colon cancer. Cancer Res 1983;43:1899-904.
6. Maskins AP, Deschner E. Tritiated thymidine incorporation into epithelial cells of normal appearing colorectal mucosa of cancer patients. J Natl Cancer Inst 1977;58:1221-4.
7. Paganelli GM, Biasco G, Santucci R, et al. Rectal cell proliferation and colorectal cancer risk level in patients with non-familial adenomatous polyps of the large bowel. Cancer 1991;68:2451-4.
8. Ponz de Leon M, Roncucci L, Donato P-Di, et al. Pattern of epithelial cell proliferation in colorectal mucosa of normal subjects and of patients with adenomatous polyps or cancer of the large bowel. Cancer Res 1988;48:4121-6.
9. Risio M, Lipkin M, Candelaresi GL, et al. Correlations between rectal cell proliferation and the clinical and pathological features of nonfamilial neoplasia of the large intestine. Cancer Res 1991;51:1917-21.
10. Risio M, Candelaresi G, Rossini FP. Bromodeoxyuridine uptake and proliferating cell nuclear antigen expression throughout the colorectal tumour sequence. Cancer Epidemiology Biomarkers and Prevention 1993;2:363-7.
11. Roncucci L, Scalmati A, Ponz de Leon M. Pattern of cell kinetics in colorectal mucosa of patients with different types of adenomatous polyps of the large bowel. Cancer 1991;68:873-8.
12. Saunders MP, Jourdan MH, Filipe MI, et al. Cell proliferation studies to define patients at increased risk of colorectal cancer [abstract]. Br J Surg 1992;79:460.
13. Mills SJ, Shepherd NA, Hall PA, et al. Proliferative compartment deregulation in the non-neoplastic colonic epithelium of familial adenomatous polyposis. Gut 1995; 36:391-4.
14. Terpstra OT, Blankenstein M, van Dees J, et al. Abnormal pattern of cell proliferation in the entire colonic mucosa of patients with colon adenoma or cancer. Gastroenterology 1987;92:704-8.
15. Deschner EE, Godbold J, Lynch HT. Rectal epithelial cell proliferation in a group of young adults. Cancer 1988;61: 2286-90.
16. O'Brien MJ, O'Keane JC, Zauber A, et al. Precursors of colorectal carcinoma. Biopsy and biologic markers [review]. Cancer. 1992;70(5,Suppl.):1317-27.
17. Lynch HT, Lanspa SJ, Boman BM, et al. Hereditary nonpolyposis colorectal cancer - Lynch syndromes I and II. Gastroenterol Clin North Am 1988;17:679-712.
18. Jass JR, Stewart S.M. Evolution of hereditary non-polyposis colorectal cancer. Gut 1992;33:783-6.
19. Fishel R, Lescoe MK, Rao MRS, et al. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell. 1993;75:1027-38.
20. Leach FS, Nicolaides NC, Papadopoulos N, et al. Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell 1993;75:1215-25.
21. Bronner CE, Baker SM, Morrison PT, et al. Mutation in the DNA mismatch repair gene homologue hMLH2 is associated with hereditary non-polyposis colorectal cancer. Nature 1994;368:258-61.
22. Lindblom A, Tannergard P, Werelius B, et al. Genetic mapping of a second locus predisposing to hereditary non-polyposis colorectal cancer. Nat Genet 1993;5:279-82.
23. Nicolaides NC, Papadopoulos N, Liu B, et al. Mutations in two PMS homologues in hereditary nonpolyposis colon cancer. Nature 1994;371:75-80.
24. Parsons R, Li G-M, Longley MJ, et al. Hypermutability and mismatch repair deficiency in RER+ tumour cells. Cell 1993;75:1227-36.
25. Parsons R, Li G-M, Longley M, et al. Mismatch repair deficiency in phenotypically normal human cells. Science 1995; 268:738-40.
26. Kolodner RD, Hall NR, Lipford J, et al. Structure of the human MSH2 locus and analysis of two Muir-Torre kindreds for msh2 mutations. Genomics 1994;24:516-26.
27. Hall NR, Williams MAT, Murday VA, et al. Muir-Torre syndrome: a variant of the cancer family syndrome. J Med Genet 1994;31:627-31.
28. Vasen HF, Mecklin J-P, Meera Khan P, et al. The international collaborative group on hereditary non-polyposis colorectal cancer. Dis Colon Rectum 1991;31:462.
29. Key G, Becker MHG, Baron B, et al. New Ki-67-equivalent murine monoclonal antibodies (MIB1-3) generated against bacterially expressed parts of the Ki-67 cDNA containing three 62 base pair repetitive elements encoding for the Ki-67 epitope. Lab Invest 1993;68:629-36.
30. Cattoretti G, Becker MHG, Key G, et al. Monoclonal antibodies against recombinant parts of the KI-67 antigen (MIB1 and MIB3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 1992; 168:357-63.
31. Goodlad RA, Levi S, Lee CY, et al. Morphometry and cell proliferation in endoscopic biopsies: evaluation of a technique. Gastroenterology 1991;101:1235-41.
32. Minitab Inc. Minitab statistical package, version 9.2. State College, PA 16801-3008.
33. Goodlad RA. Microdissection-based techniques for the determination of cell proliferation in gastrointestinal epithelium: application to animal and human studies. In: Cell biology: a laboratory handbook. London: Academic Press, 1993.
34. Risio M. Methodological aspects of using immunohistochemical cell proliferation biomarkers in colorectal carcinoma chemoprevention. J Cell Biochem 1994;(suppl 19):61-7.
35. 3H] thymidine techniques to measure cell proliferation. Cell Tissue Kinetics 1981;14: 111-20.
36. McCormick D, Chong H, Hobbs C, et al. Detection of the KI-67 antigen in fixed and wax-embedded sections with the monoclonal antibody MIB1. Histopathology 1993;22: 335-60.
37. Alberts DS, Einspahr J. Validation of proliferation indices as surrogate endpoint biomarkers. J Cell Biochem 1994;(suppl 19):76-83.
38. Fireman Z, Pozen P, Fine N, et al. Reproducibility studies and effects of bowel preparations on the measurements of rectal epithelial proliferation. Cancer Lett 1989;45:59-64.
39. Lynch PM, Wargovich MJ, Lynch HT, et al. A follow-up study of colonic epithelial proliferation as a biomarker in a native-American family with hereditary nonpolyposis colon cancer. J Natl Cancer Inst 1991;83:951-4.
40. O'Sullivan KR, Mathias PM, Beattie S, et al. The effect of colonic site of biopsy on cell proliferation profiles using BRDU incorporation as a measure of cell proliferation. Eur J Cancer Prev 1992;1:381-3.
41. Potten CS, Kellett M, Roberts SA, et al. Measurement of in vivo proliferation in human colorectal mucosa using bromodeoxyuridine. Gut 1992;33:71-8.
42. Potten CS, Kellett M, Rew DA, et al. Proliferation in human gastrointestinal epithelium using bromodeoxyuridine in vivo: data for different sites, proximity to tumour, and polyposis coli. Gut 1992;33:524-9.
43. Cats A, De Vries EGE, Kleibeuker JH. Proliferation rate in hereditary non-polyposis colon cancer. J Natl Cancer Inst 1991;83:1687-8.
44. Cats A, de Vries EGE, Zwart N, et al. Epithelial proliferation in different segments of the colon in hereditary nonpolyposis colon cancer (HNPCC) [abstract]. Gastroenterology 1992;102:A348.
45. Terpstra OT, Blankenstein M, van Dees J, et al. Abnormal pattern of cell proliferation in the entire colonic mucosa of patients with colon adenoma or cancer. Gastroenterology 1987;92:704-8.
46. Ponz de Leon M, Roncucci L, Donato P-Di, et al. Pattern of epithelial cell proliferation in colorectal mucosa of normal subjects and of patients with adenomatous polyps or cancer of the large bowel. Cancer Res 1988;48:4121-6.
47. Deschner EE, Godbold J, Lynch HT. Rectal epithelial cell proliferation in a group of young adults. Cancer 1988;61: 2286-90.
48. Markowitz JF, Aiges HW, Cunningham-Rundles S, et al. Family syndrome: marker studies. Gastroenterology 1986; 91:581-9.
49. Matthew JA, Pell JDP, Prior A, et al. Validation of a simple technique for the detection of abnormal mucosal cell replication in humans. Eur J Cancer Prev 1994;3:337-44.
50. Kashtan H, Stern HS, Jenkins DJA, et al. Colonic fermentation and markers of colorectal cancer risk. Am J Clin Nutr 1992;55:723-8.
51. Nakamura S, Kino I, Baba S. Cell kinetic analysis of background colonic mucosa of patients with intestinal neoplasms by ex vivo autoradiography. Gut 1988;29:997-1002.
52. Nakamura S, Kino I, Baba S. Nuclear DNA content of isolated crypts of background colonic mucosa from patients with familial adenomatous polyposis and sporadic colorectal cancer. Gut 1993;34:1240-4.
53. Jass JR. Failure to detect colonic mucosal hyperproliferation in mutation positive members of a family with hereditary non-polyposis colorectal cancer. Histopathology 1997;30: 201-7.
54. Jass JR. Colorectal adenoma progression and genetic change: is there a link? Ann Med 1995;27:301-6.
55. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990;61:759-67.
56. Kinzler KE, Vogelstein B. Lessons from hereditary colorectal cancer. Cell 1996;87:159-70.
57. Jass JR, Edgar S. Unicryptal loss of heterozygosity in hereditary non-polyposis colorectal cancer. Pathology 1994;26: 414-17.
58. Williams GT, Geraghty JM. Normal colonic mucosa in hereditary non-polyposis colorectal cancer shows no generalised increase in somatic mutation. Br J Cancer 1995;71:1077-80.
59. Hall C, Youngs D, Keighley MRB. Crypt cell production rates at various sites around the colon in Wistar rats and humans. Gut 1992;33:1528-31.
60. Lehy T, Abitbol JL, Mignon M. Influence de la preparation rectale par lavement sur la proliferation cellulaire dans la muquese rectale normale de l'homme. Gastroenterol Clin Biol 1984;8:216-20.
61. Fireman Z, Rozen P, Fine K, et al. Influence of demographic parameters on rectal epithelial proliferation. Cancer Lett 1989;47:133-40.
62. Kennedy MFG, Tutton PMJ, Barkla DH. Comparison of the circadian variation in cell proliferation in normal and neoplastic colonic epithelial cells. Cancer Lett 1985;28:169-75.
63. Sigdestad CP, Bauman J, Lesher S. Diurnal fluctuations in the numbers of cells in mitosis and DNA synthesis in the jejunum of the mouse. Exp Cell Res 1969;58: 159-62.
64. Bayer BM, Beaven MA. Evidence that indomethacin reversibly inhibits cell growth in the G1 phase of the cycle. Biochem Pharmacol 1979;28:441-3.
65. Logan RFA, Little J, Hawtin PG, et al. Effect of aspirin and non-steroidal anti-inflammatory drugs on colorectal adenomas: case-control study of subjects participating in the Nottingham faecal occult blood screening programme. BMJ 1993;301:285-8.
66. Key FB, McClean D, Mathers JC. Tissue hypertrophy and epithelial proliferation rate in the gut of rats fed on bread and haricot beans (Phaseolus vulgaris). Br J Nutr 1996;76: 273-86.